Through the power of sensory, stimulating the right side of the brain in dementia patients is the purpose of a new Luzerne County program. Embassy of ...

The U.S. Food and Drug Administration has approved the marketing of a new tool to that can test a person’s blood to diagnose ...

A group of studies from the Indiana University School of Medicine has found that quick digital brain health screenings during ...

Sanofi's $470M Vigil Neuroscience, Inc. acquisition highlights VG-3927's potential in Alzheimer's. Click here to find out why ...

The Food and Drug Administration (FDA) cleared the first blood test recently to help diagnose Alzheimer's disease.

Alzheimer's disease is the most common cause of dementia and affects more than a tenth of Americans aged 65 and older.

An afternoon snooze might seem appealing to middle-aged folks and seniors, but these naps could carry a high cost.

The Alzheimer’s Foundation of America is hosting a free educational conference next week in Portland. The conference will take place from 11 a.m. to 1 p.m. Wednesday at the Portland Regency Hotel and ...

Researchers at University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's disease ...

Researchers at the University of California San Diego School of Medicine have developed a gene therapy for Alzheimer's ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Using a new artificial intelligence method, researchers at Columbia University Vagelos College of Physicians and Surgeons can ...